Sign in
Download Opera News App

Digital Technology


PC Mobile Software



New, Easier Way To Report Medical Side Effects Through Your Phone.

The Pharmacy and Poisons Board (PPB) in partnership with USAID, developed a system that is mobile - based to provide a reporting platform in form of mobile application for iPhone operating systems, android and USSD solution. Often do medical services, blood transfusion and or prescribed medications lead to gross adverse reactions on the patients. Therefore, it is good news for consumers of any medical supplies to report the side effects easily and conveniently, after the Poisons and Pharmacy Board launched the Mobile Pharmacovigilance Electronic Reporting System (mPvERS).

Chief Administrative Secretary for Health Dr. Rashid Aman, launched the system and he described it, "as a step in the right direction in enabling the public to enjoy quality, safe, and efficacious health products and technologies." He further added that, "The mobile - based solution provides a reporting platform in form of a mobile application for both android and iPhone Operating Systems as well as a USSD solution." According to World Health Organisation (WHO), medicinal products and medical services may have side effects which could be undesirable or unexpected to patients. For instance, even after undergoing rigorous testing for safety and efficacy, as well as clinical trials, some side effects only emerge when these products have been consumed by a heterogenous population including people with concurrent diseases therefore, putting them at risk to side effects therein.

It was during the virtual launch of the system that was developed by the Pharmacy and Poisons Board with support from the USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program on Wednesday that CAS Dr. Aman equally pointed out that, "the mobile - based solution is developed to supplement the existing national reporting system PvERS II, launched in March 2021 to increase and improve consumer reporting and AEFI reporting." It is crucial to note that this Pharmacovigilance electronic reporting system (PvERS) has been in operation since 2013 however, was upgraded in March 2021, to include reporting of adverse events following immunisation, medication errors, transfusion reactions and incidents from medical devices that were quite alarming and of public health concern.

Dr. Fred Siyoi, the Chief Executive Officer at the Pharmacy and Poisons Board said that, "over 16,000 reports have been received by the board before which have been used to inform policy change, review treatment guidelines, and various regulatory actions." He added that, this electronic system will go a long way in strengthening reporting and vigilance on safety quality issues for health products and technologies in Kenya both by general public and health care workers at large. He echoed that reports that Such reports that go side by side long in assisting regulatory bodies make decisions on whether use of some medicinal products should be discontinued or improved.

How the The Pharmacovigilance electronic reporting system (PvERS) operates?

The USSD code, #271# or the app “mPVERS” will see health care practitioners or the general public feed in details of what side effects they experienced, caused by what medicines or medical devices, how long the side effects have lasted as well as provide an opportunity for the consumer to attach any photos that will help in their report.

All health care workers are required to register first before they can submit reports. The registration details will be used for communication and follow up. Equally, any member of the public is able to report any cases of adverse drug reactions or incidents involving medical devices. For minors, parents/gaurdians can report on their behalf.

What happens when you report?

All the information is received in confidence and will only be accessed by designated PPB staff. The Board will investigate the cases and where possible, provide feedback on the status/outcome of the review. The details of the reporter will always remain anonymous. The information collected will be used to improve patient safety.

The Patient’s identity is held in strict confidence and the designated PPB staff shall not disclose the reporter’s identity in response to any public request. Information submitted by you will contribute to the improvement of drug safety and therapy in Kenya.

Content created and supplied by: Dr. Samuel Ondimu (via Opera News )

Mobile Pharmacovigilance PPB Pharmacy and Poisons Board Rashid Aman


Load app to read more comments